665436

Teva Branded Pharmaceutical Products R&D — FEI 3004442422

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 19, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Horsham, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information
890821 CFR 314.81(b)(2)(i)Summary